neurodegenerative

(redirected from Neurodegenerative disease)
Also found in: Dictionary, Medical, Wikipedia.

neurodegenerative

[‚nu̇·rō·di′jen·rəd·iv]
(pathology)
Characterized by the gradual and progressive loss of nerve cells.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
The collaborative team has applied the latest proteomic techniques to the differential diagnosis of neurodegenerative diseases utilizing blood serum.
Presenting their research at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting, researchers are not sure why spontaneous and unexplained disturbance in REM sleep should lead to a neurodegenerative disease like Parkinson's, but new longitudinal imaging data show a clear correlation between idiopathic REM behavior disorder and dysfunction of the dopamine transporter system involved in a wide range of vital brain functions, including memory and motor control.
Many neurodegenerative diseases arise when glial cells are damaged or destroyed, causing neurons to malfunction and eventually die.
The parties will collaborate to evaluate the effect of therapies on the progression of neurodegenerative diseases in humans such as Alzheimer disease.
South San Francisco, Calif.-based iPierian, Inc., on May 21 announced the first development programs in its drug pipeline: monoclonal antibodies to treat neurodegenerative diseases by targeting the Tau protein and the Complement pathway.
It was reported yesterday that the collaboration is aimed at identifying, validating and developing deubiquitinating enzyme inhibitors for the treatment of neurodegenerative diseases.
Licensing the CBD technology platform allows Enigma, and its partner, Cerveau Technologies Inc., to continue to execute the collective strategy of providing biomarkers to industry and academia to accelerate research in the field of Neurodegenerative Disease.
NIA leads the federal government effort conducting and supporting research on aging and the health and well-being of older people as well as provides information on age-related cognitive change and neurodegenerative disease.
FORMA Therapeutics and the University of Oxford have entered into a collaboration and license agreement to identify, validate and develop deubiquitinating enzyme (DUB) inhibitors for the treatment of neurodegenerative diseases. DUBs are a family of over a hundred proteases that play important roles in protein and cellular homeostasis, processes that are critical to normal cell function.
Summary: Naturally occurring molecules known as lipid mediators can halt the progression of the neurodegenerative disease
The collaboration is focused on using [F-18]MK-6240 as a biomarker in Janssen neurodegenerative disease research studies.